FIGO's Committee on Women's Cancer has adopted an updated 2026 staging system for gestational trophoblastic neoplasia (choriocarcinoma, placental site and epithelioid trophoblastic tumours, post-molar rising hCG), with explanatory notes on the changes.
Guideline
Ngan et al. FIGO staging for gestational trophoblastic neoplasia: 2026